News

Adults with Prader-Willi syndrome (PWS) need substantial support with daily activities, including personal care, social interactions, and problem solving, according to a study from Japan. The results suggest “that once adulthood is reached, daily living skills and adaptive functioning remain largely consistent over time,” the researchers wrote. “Early intervention…

Epigenome editing, a technique that alters the chemical switches that turn genes on or off, can reactivate genes from the mother that are usually silent in Prader-Willi syndrome (PWS), a study using stem cells has found. According to the researchers, these laboratory findings provide new evidence that epigenome editing may…

Probiotic supplementation may increase the gut abundance of beneficial bacteria of the Bifidobacterium genus and improve social interactions in people with Prader–Willi Syndrome (PWS), without causing gastrointestinal adverse events. These are the main findings of a review study that pooled data from appropriately controlled clinical trials testing supplements of…

The injectable therapy setmelanotide, being developed by Rhythm Pharmaceuticals for Prader-Willi syndrome (PWS), curbs hyperphagia, or uncontrollable hunger, and reduces body weight in children and adults with obesity due to PWS. Those are the early findings of an exploratory Phase 2 clinical trial, ongoing at a single U.S.

Working closely with caregivers and clinical experts, an international team of scientists has adapted an eye-tracking test to more objectively measure the intense, constant hunger — called hyperphagia — that affects people with Prader-Willi syndrome (PWS). “By integrating stakeholder insights, we enhanced feasibility, accessibility and data quality,” demonstrating “the…

Sodium-glucose cotransporter-2 inhibitors (SGLT2is), a class of type 2 diabetes medications, may help improve blood sugar levels and support kidney health markers in adults with Prader-Willi syndrome (PWS) and type 2 diabetes, according to a study in France. Despite these benefits, the treatment did not lead to significant weight…

The experiences of siblings of individuals with Prader-Willi Syndrome (PWS) change as they age, as do their support needs, and are associated with variable parents’ perspectives, according to a recent study. Tailoring advice and support to the life stages of siblings, as well as involving them in discussions about…

Bright Minds Biosciences has launched a clinical program to evaluate whether its oral therapy candidate BMB-105 can ease hyperphagia, or insatiable hunger, and other behavioral symptoms in people with Prader-Willi syndrome (PWS). The experimental therapy targets the underlying disease mechanisms of PWS, and as such, is a “novel”…

Long-term treatment with human growth hormone, also known as somatropin, does not seem to influence mortality in people with Prader-Willi syndrome (PWS), but may increase the risk of developing type 2 diabetes, a study from South Korea found. The risk of type 2 diabetes increased by 6%…

Prader-Willi syndrome (PWS) is associated with shorter life expectancy, impaired quality of life, and high healthcare and caregiving costs — all of which place a heavy burden on families and the healthcare system. That’s according to a systematic review of more than 130 published studies. Data also found that…